PT89494A - Processo para a preparacao de 4-alquil-1,4-dihidropiridinas com actividade antagonista do factor activador de plaquetas - Google Patents

Processo para a preparacao de 4-alquil-1,4-dihidropiridinas com actividade antagonista do factor activador de plaquetas

Info

Publication number
PT89494A
PT89494A PT89494A PT8949489A PT89494A PT 89494 A PT89494 A PT 89494A PT 89494 A PT89494 A PT 89494A PT 8949489 A PT8949489 A PT 8949489A PT 89494 A PT89494 A PT 89494A
Authority
PT
Portugal
Prior art keywords
pyridines
platelets
dihydro
alkyl
preparation
Prior art date
Application number
PT89494A
Other languages
English (en)
Other versions
PT89494B (pt
Inventor
Carlos Sunkel
Miguel Fau De Casa-Juana
Luis Santos
Pilar Ortega
Jaime Priego
Mariano Sanchez-Crespo
Original Assignee
Alter Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alter Sa filed Critical Alter Sa
Publication of PT89494A publication Critical patent/PT89494A/pt
Publication of PT89494B publication Critical patent/PT89494B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT89494A 1988-01-21 1989-01-20 Processo para a preparacao de 4-alquil-1,4-dihidropiridinas com actividade antagonista do factor activador de plaquetas PT89494B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3801717A DE3801717C1 (pt) 1988-01-21 1988-01-21
EP91500103A EP0531598A1 (en) 1988-01-21 1991-09-09 1,4-Dihydropyridines with paf-antagonistic activity

Publications (2)

Publication Number Publication Date
PT89494A true PT89494A (pt) 1989-10-04
PT89494B PT89494B (pt) 1994-03-31

Family

ID=40279084

Family Applications (2)

Application Number Title Priority Date Filing Date
PT89494A PT89494B (pt) 1988-01-21 1989-01-20 Processo para a preparacao de 4-alquil-1,4-dihidropiridinas com actividade antagonista do factor activador de plaquetas
PT100848A PT100848A (pt) 1988-01-21 1992-09-08 1,4-di-hidropiridinas com actividade antagonista do factor agregador das plaquetas (paf)

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT100848A PT100848A (pt) 1988-01-21 1992-09-08 1,4-di-hidropiridinas com actividade antagonista do factor agregador das plaquetas (paf)

Country Status (19)

Country Link
EP (2) EP0325187B1 (pt)
JP (2) JPH01233273A (pt)
KR (1) KR910008348B1 (pt)
AR (1) AR248137A1 (pt)
BR (1) BR9203580A (pt)
CA (2) CA1332838C (pt)
CZ (1) CZ278692A3 (pt)
DE (1) DE3801717C1 (pt)
DK (1) DK25989A (pt)
ES (1) ES2052783T3 (pt)
FI (1) FI924018A (pt)
GR (1) GR3006934T3 (pt)
HU (1) HUT65253A (pt)
IE (2) IE890136L (pt)
MX (1) MX9204642A (pt)
NO (1) NO923489L (pt)
PL (1) PL295861A1 (pt)
PT (2) PT89494B (pt)
ZA (2) ZA89519B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3801717C1 (pt) * 1988-01-21 1989-05-24 Alter S.A., Madrid, Es
EP0801065A4 (en) * 1994-07-29 1998-02-25 Nikken Chemicals Co Ltd 1,4-DIHYDROPYRIDINE COMPOUNDS AND MEDICAL COMPOSITIONS CONTAINING THEM
WO1999025347A2 (en) * 1997-11-14 1999-05-27 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
US6566359B1 (en) 2002-05-20 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs
US20180104251A1 (en) 2015-03-09 2018-04-19 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for the treatment of glioblastoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4761420A (en) * 1986-06-13 1988-08-02 Laboratoires Syntex S.A. Antihypertensive dihydropyridine derivatives
DE3801717C1 (pt) * 1988-01-21 1989-05-24 Alter S.A., Madrid, Es

Also Published As

Publication number Publication date
DK25989D0 (da) 1989-01-20
DK25989A (da) 1989-07-22
CA1332838C (en) 1994-11-01
FI924018A0 (fi) 1992-09-08
PL295861A1 (en) 1993-05-04
JPH05208958A (ja) 1993-08-20
HUT65253A (en) 1994-05-02
ZA925692B (en) 1993-03-02
EP0531598A1 (en) 1993-03-17
KR890011842A (ko) 1989-08-22
EP0325187B1 (en) 1992-11-11
JPH0742271B2 (ja) 1995-05-10
CA2074419A1 (en) 1993-03-10
AR248137A1 (es) 1995-06-30
NO923489D0 (no) 1992-09-08
IE890136L (en) 1989-07-21
PT89494B (pt) 1994-03-31
IE922412A1 (en) 1993-03-10
CZ278692A3 (en) 1993-12-15
BR9203580A (pt) 1993-04-13
MX9204642A (es) 1993-12-01
FI924018A (fi) 1993-03-10
HU9202873D0 (en) 1992-11-30
KR910008348B1 (ko) 1991-10-12
PT100848A (pt) 1993-10-29
JPH0552827B2 (pt) 1993-08-06
ZA89519B (en) 1989-10-25
EP0325187A1 (en) 1989-07-26
JPH01233273A (ja) 1989-09-19
GR3006934T3 (pt) 1993-06-30
ES2052783T3 (es) 1994-07-16
DE3801717C1 (pt) 1989-05-24
NO923489L (no) 1993-03-10

Similar Documents

Publication Publication Date Title
PT94956A (pt) Processo para a preparacao de azois com actividade pesticida
PT90216A (pt) Processo para a preparacao de polipeptidos com actividade osteogenica
BR8603901A (pt) Processo para a preparacao de 2-oxo-1,3-dioxolanas e seu uso
PT90523A (pt) Processo para a preparacao de adsorvatos de ranitidina
BR8700097A (pt) Processo para a preparacao de 2-oxo-1,3-dioxolanas e seu uso
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT89705A (pt) Processo para a preparacao de 2', 3'-didesoxi-2', 2'-difluoronucleosidos
PT90293A (pt) Processo para a preparacao de macrolidos
PT91895A (pt) Processo para a preparacao de 9h-purinas substituidas
PT89258A (pt) Processo para a preparacao de carbinois com actividade anti-fungica
PT90798A (pt) Metodos para a producao de novos polipeptideos com actividade anticoagulante
PT89269A (pt) Processo para a preparacao de 2,5-diaril-tetra-hidrofuranos uteis como antagonistas do factor activador de plaquetas
BR8906327A (pt) Processo para a preparacao de organoclorossilanos
PT92325A (pt) Processo para a preparacao de polieter-poliois com insaturacao reduzida
PT89249A (pt) Processo para a preparacao de novos derivados de piperidinilo 1,4-dissubstituido com actividade terapeutica
PT90854A (pt) Processo para a preparacao de 1-aril-2-naftoilaminas
PT88614A (pt) Processo para a preparacao de antagonistas do factor activador de plaquetas di-hidropiridinicos
PT90645A (pt) Processo para a preparacao de agentes diureticos de glutarimida substituida com cicloalquilo
PT92638A (pt) Processo para a preparacao de poliazamacrociclos mono-n-alquilados
PT88260A (pt) Processo para a preparacao de derivados de imidazopiridazina com actividade citotoxica
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT91286A (pt) Processo para a preparacao de sistemas de expressao de pectinas-liases
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT91027A (pt) Processo para a preparacao de derivados peptidicos

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930923

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970331